Niva Bupa Health Insurance Company Limited has informed the Exchange regarding a press release dated May 07, 2025, titled "Press Release-Audited Financial Results for the quarter and year ended March 31, 2025".
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Niva Bupa reported strong FY25 results, with Profit After Tax more than doubling to ₹214 crore from ₹82 crore in FY24, a 161% year-on-year jump. Gross Written Premium (GWP) for FY25 stood at ₹7,407 crore, up 32% YoY, while Q4 FY25 GWP rose 36% to ₹2,395 crore. On an adjusted basis (accounting for IRDAI's new 1/N premium recognition framework from October 2024), FY25 GWP grew 21% to ₹6,762 crore. Operational metrics improved across the board — Claims Settlement Ratio rose to 92.4% (from 91.9%), Expense of Management dropped to 37.4% (from 39.3%), and Solvency Ratio strengthened to 3.03 (from 2.55). Retail Health Market Share also inched up from 9.1% to 9.4%.
Strong top-line growth, sharp profitability expansion, and improved operational efficiency signal healthy business momentum, likely to be viewed positively by investors. The strengthening solvency ratio and better claims performance reduce underwriting risk concerns, while the market share gain reinforces the company's competitive positioning in India's growing health insurance sector.